Jazz Pharmaceuticals
JAZZ
#2291
Rank
A$9.78 B
Marketcap
$161.14
Share price
3.03%
Change (1 day)
-4.45%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): A$0.70 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$4.06 Billion. , an increase over its 2023 earnings that were of A$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 A$0.73 B57.87%
2023 A$0.46 B-179.92%
2022 -A$0.59 Billion230.37%
2021 -A$0.18 Billion-141.02%
2020 A$0.42 B-39.45%
2019 A$0.70 B-14.2%
2018 A$0.82 B20.03%
2017 A$0.68 B-17.15%
2016 A$0.82 B22.14%
2015 A$0.67 B187.64%
2014 A$0.23 B-50.79%
2013 A$0.48 B73.63%
2012 A$0.27 B41.69%
2011 A$0.19 B116.61%
2010 A$90.07 M262.77%
2009 A$24.83 M-111.33%
2008 -A$0.22 Billion1.31%
2007 -A$0.22 Billion77.8%
2006 -A$0.13 Billion36.59%
2005 -A$89.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$3.73 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$3.26 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.26 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-A$0.44 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel